Bicoll News

Medicinal Chemistry: Impact and role- Podcast

Gabriel Garcia, Ph.D. : Impact and Role of Medicinal Chemistry in the area of Drug Discovery: Stay ahead of the game. Gabriel Garcia has a Ph.D. in Organic Chemistry and has worked over the last 30 years in several academic …

Read more

Preliminary Pre-Clinical Evaluation of a Molecule With Anti-Seizure Effects

BICS01 Epilepsy ASD molecule

Despite the availability of around 30 anti-seizure drugs, drug-resistant epilepsy remains a significant clinical and societal burden. We report the first promising result of a new candidate BICS01.

Planegg / Martinsried (Germany) – January 7, 2022 – Bicoll, an expert in synthesizing new and relevant small molecules as starting points for accelerated drug development, worked together with its partners at the University College London, FutureNeuro, and Royal College of Surgeons to publish data for a promising anti-seizure drug candidate BICS01 in Frontiers in Neurology.

Read more

Bicoll GmbH Announces New Shareholder Trustee for Bicoll Biotechnology (Shanghai) Co. Ltd.

Planegg / Martinsried (Germany) – October 1, 2021, Bicoll GmbH approved Prof. Dr. Heinrich Arnold as shareholder trustee of its 100% daughter company Bicoll Biotechnology (Shanghai) Co. Ltd.

Bicoll Group is delighted to welcome such a renowned digital innovation and transformation guru and entrepreneurial mind such as Prof. Dr. Heinrich Arnold. Managing Director of Bicoll, Dr. Kai Lamottke, states: “Bicoll will definitely enormously profit from Dr. Arnold 20 years professional competence in different fields, such as supervision of start-ups and digital transformation knowledge. It is an asset to work with him.”

Read more

Research Taxation Support for German Entities: Forschungszulage

Forschungszulage in Deutschland

Seit dem 01.01.2020 bekommen Unternehmen mit Sitz in Deutschland steuerliche Begünstigungen für ihre Forschungsausgaben. Auch die Auftragsforschung darf zu 15% geltend gemacht werden. Das bedeutet, einen Auftrag bei Bicoll koennen Unternehmen nun zu 15% als Forschungszulage zurückerstattet bekommen. Seit 20 …

Read more

Bicoll Celebrates 20th Anniversary

Bicoll celebrates 20 year anniversary

This year marks the 20th anniversary of Bicoll. On November 29th, 2000 we embarked on this exciting journey to deliver research services and natural compound libraries, and enable our partners to develop new effective drugs for patients. We would like …

Read more

Patient-twin on inflammatory diseases

Bicoll joins in HVC Kyoto 2020. The provided pitch dwell upon current project in the field of inflammatory diseases. PATIENT-TWIN ON INFLAMMATORY DISEASES (PTID)Precision medicine: individualized discovery of compounds through lab-on-a-chip technology using plant libraries and patient samples for the …

Read more

Natural compounds experts at German pavilion, BioJapan 2020

Bicoll exhibits at BioJapan 2020, 14-16 October, Yokohama Bio Japan is Asia’s Premier Partnering Event for the Global Biotechnology Industry. For almost two decades It has played an important role in facilitating interaction between Japanese and global companies/organizations and stimulating …

Read more

Join us at Biotechgate Partnering May 9th -13th digitallyBiotechgate Partnering
+ +